#None #Austin #Wegovy #Choose Health #GLP-1 Monitoring

Choose Health Launches At-Home Blood Testing for GLP-1 Medications

In an era where weight loss and diabetes management are increasingly important, Choose Health has stepped up to offer a significant innovation with their new GLP-1 Health Monitoring Panels. As of April 2026, this Austin-based company is providing at-home blood tests designed specifically for individuals using GLP-1 receptor agonist medications like Ozempic, Wegovy, and Mounjaro. With the surge of GLP-1 prescriptions tripling since 2020, and with nearly 1 in 8 adults in the U.S. reporting the use of these medications, Choose Health aims to fill a crucial monitoring gap that has existed until now.

The Necessity of Monitoring

The recent approval of the first oral form of Wegovy pill in late 2025 by the FDA further underscores the growing reliance on GLP-1 medications. However, according to recent data, a significant portion of patients lacks convenient access to blood tests necessary to track how their bodies respond to these medications.

Dr. Alan Farrell, Chief Medical Officer at Choose Health, emphasized the importance of monitoring: "GLP-1 medications are increasingly used by people who want to optimize their metabolic health as well as lose weight. Understanding how your body responds internally is crucial, and tracking biomarkers provides that visibility."

Features of the GLP-1 Health Monitoring Panels

The company offers two different panel options, making it accessible for various health needs.

• - Basic Panel: This kit measures eight critical biomarkers, including liver enzymes, kidney function indicators, lipase, and blood sugar levels.
• - Comprehensive Panel: For those seeking a deeper dive into their health metrics, this option includes all Basic Panel tests plus an additional 10 biomarkers. With 18 total blood markers tested, users can gain insights into cardiometabolic health, lipid levels, vitamin D, and more.

To utilize the service, clients simply order a panel online, collect a small blood sample through a finger prick in the comfort of their home, and mail it off to a CLIA-certified lab using a prepaid envelope. The results, carefully reviewed by physicians, are then made available through a secure online dashboard.

Building Health Awareness from Home

Choose Health aims to empower users by making reactive health monitoring accessible and straightforward. Mark Holland, the founder, stated, "We’ve been focused on health improvements from the comfort of one’s home for years, and these health panels are designed to provide real-time insights into what's occurring within the body."

This service not only alleviates the need for doctor's visits for routine health tracking but also encourages proactive health management. Patients are increasingly seeking ways to take their health into their own hands, and Choose Health's solution serves as an excellent tool for that.

Availability and Future Plans

The GLP-1 Health Monitoring Panels are currently available for purchase at ChooseHealth.io, with no prescriptions necessary. Furthermore, the company is set to release a clinical outcomes report in mid-2026, based on data collected from over 150,000 at-home blood tests, further showcasing the effectiveness of their monitoring tools.

Conclusion

The introduction of Choose Health’s GLP-1 Health Monitoring Panels is an important milestone for individuals relying on GLP-1 medications for weight loss or diabetes management. By incorporating a simple, accessible method to monitor their health at home, it enables users to take informed steps toward achieving their health goals. For anyone currently on GLP-1 medications or considering them, this is a pivotal resource that advances the future of personal health management.